abstract |
According to the present invention, inhibiting VEGF mRNA translation by orally administering a pharmaceutical once, twice or three times daily to a subject in need of post-transcriptional inhibition that inhibits VEGF expression. Compounds that are useful in the manufacture of a method or medicament for post-transcriptional inhibition of VEGF expression in the subject are provided. [Selection figure] None |